Inhaled nitric oxide (iNO) therapy for preterm infants after 7 days of age: a scoping review
Not Applicable
- Conditions
- Bronchopulmonary dysplasia (BPD), Pulmonary hypertension, Neonatal hypoxic respiratory failure
- Registration Number
- JPRN-UMIN000051498
- Lead Sponsor
- Kitasato University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
i) Infants born more than 37 weeks of gestational age ii) Initiation of iNO is before 7 days of life iii) Infants with congenital malformation syndrome and a chromosomal abnormality iv) Animal and in-vitro studies
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Initiation criteria of iNO
- Secondary Outcome Measures
Name Time Method postnatal day of the iNO initiation, iNO concentration (ppm), duration of iNO, discontinuation criteria of iNO, other drugs, adverse effects